GEXVal Selected as Semifinalist for AEA2024
2024/9/3
GEXVal Inc.September 3, 2024 GEXVal Inc. (President and CEO: Juran Kato, PhD, Kanagawa, Japan) is pleased to a […]
GEXVal CEO to Present at Data Science Meeting of Genome Technology Research
2024/9/2
GEXVal Inc.September 2, 2024 Dr. Juran Kato, CEO of GEXVal Inc., will be presenting at the 8th Data Science […]
GEXVal to Present at BIO Asia-Taiwan 2024 Investment Summit
2024/7/12
GEXVal Inc.July 12, 2024 GEXVal to Present at BIO Asia-Taiwan 2024 Investment Summit GEXVal Inc. will be pre […]
GEXVal Completes Phase I Clinical Trial of GXV-001 in Australia
2024/7/1
GEXVal Inc.July 1, 2024 GEXVal Completes Phase I Clinical Trial of GXV-001 in Australia We are pleased to anno […]
GEXVal CEO Delivers Lecture at Kindai University*
2024/6/29
GEXVal Inc.June 29, 2024 GEXVal CEO Delivers Lecture at Kindai University* Juran Kato, PhD, President and CE […]